Medicare Part D Coverage Determination Request Form Now Available
A standardized coverage determination request form for the Part D Medicare Prescription Drug benefit has been developed through a collaborated effort between an AMA Part D work group and the health insurance industry. ACP has been an active participant within this process. The Centers for Medicare and Medicaid Services (CMS) is requesting that all plans use this form as a “best practice” and representatives of the health insurance industry expect wide acceptance.
The development of this standardized form is in response to providers’ complaints regarding complications caused by each plan having a different exceptions/appeals form.
The form can be used to request approval for a drug not in a plan’s formulary, for an exception to a formulary tier, and for providing data to meet prior authorization requirements. The form can be used for all drugs except those specifically not covered under the Part D benefit (i.e. barbiturates, benzodiazepines, fertility drugs, drugs prescribed for weight loss, weight gain or hair growth, over the counter drugs or prescription vitamins other than prenatal vitamins and fluoride preparations) and biotech or high cost specialty drugs.
The form will be available on most plan websites within the next several weeks and can be currently downloaded from CMS
.
Acrobat PDF format.
Download Acrobat Reader
software for free from Adobe.
Problems with PDFs?
Practice Management Discussion Groups
Multimedia Learning Resources
More Related Links:
Discount Ending Soon!
Register now for Internal Medicine 2010 in Toronto, Canada and save! Join us at the premier scientific event in internal medicine and the subspecialties. View pricing details.
Your Opinion Counts
Twice a year, ACP participates in a journal readership survey of random internists. If you receive one of these surveys in the mail, please indicate if you read our journals and answer the questions about your reading habits of our journals.
Your voice in these surveys is very important to ACP and enables us to continue to produce the high-quality publications that you expect.
Find out more.